临床医学工程
臨床醫學工程
림상의학공정
Clinical Medical & Engineering
2015年
11期
1481-1482
,共2页
顺尔宁%小剂量阿奇霉素%上气道咳嗽综合征%疗效
順爾寧%小劑量阿奇黴素%上氣道咳嗽綜閤徵%療效
순이저%소제량아기매소%상기도해수종합정%료효
Singulair%Small dose of azithromycin%Upper airway cough syndrome%Efficacy
目的 分析顺尔宁联合小剂量阿奇霉素治疗上气道咳嗽综合征的疗效. 方法 随机选取我院门诊2014年2月1日至2015年1月1日期间的60例上气道咳嗽综合征患儿, 其中, 30例接受小剂量阿奇霉素治疗的患儿被设为对照组, 30例接受顺尔宁联合小剂量阿奇霉素治疗的患儿被设为试验组, 观察、 比较两组患儿的临床治疗结果. 结果 治疗后, 试验组的咳嗽评分为(0.81士0.33) 分, 优于对照组的 (1.56士0.72) 分, 差异具有统计学意义 (P<0.05). 试验组的治疗有效率为93.33%, 显著高于对照组的73.33%, 差异具有统计学意义 (P<0.05). 结论 顺尔宁联合小剂量阿奇霉素治疗上气道咳嗽综合征的疗效显著, 可有效改善咳嗽等症状, 值得临床推广应用.
目的 分析順爾寧聯閤小劑量阿奇黴素治療上氣道咳嗽綜閤徵的療效. 方法 隨機選取我院門診2014年2月1日至2015年1月1日期間的60例上氣道咳嗽綜閤徵患兒, 其中, 30例接受小劑量阿奇黴素治療的患兒被設為對照組, 30例接受順爾寧聯閤小劑量阿奇黴素治療的患兒被設為試驗組, 觀察、 比較兩組患兒的臨床治療結果. 結果 治療後, 試驗組的咳嗽評分為(0.81士0.33) 分, 優于對照組的 (1.56士0.72) 分, 差異具有統計學意義 (P<0.05). 試驗組的治療有效率為93.33%, 顯著高于對照組的73.33%, 差異具有統計學意義 (P<0.05). 結論 順爾寧聯閤小劑量阿奇黴素治療上氣道咳嗽綜閤徵的療效顯著, 可有效改善咳嗽等癥狀, 值得臨床推廣應用.
목적 분석순이저연합소제량아기매소치료상기도해수종합정적료효. 방법 수궤선취아원문진2014년2월1일지2015년1월1일기간적60례상기도해수종합정환인, 기중, 30례접수소제량아기매소치료적환인피설위대조조, 30례접수순이저연합소제량아기매소치료적환인피설위시험조, 관찰、 비교량조환인적림상치료결과. 결과 치료후, 시험조적해수평분위(0.81사0.33) 분, 우우대조조적 (1.56사0.72) 분, 차이구유통계학의의 (P<0.05). 시험조적치료유효솔위93.33%, 현저고우대조조적73.33%, 차이구유통계학의의 (P<0.05). 결론 순이저연합소제량아기매소치료상기도해수종합정적료효현저, 가유효개선해수등증상, 치득림상추엄응용.
Objective To analyze the clinical effect of singulair combined with small dose of azithromycin in the treatment of upper airway cough syndrome. Methods 60 cases of patients with upper airway cough syndrome in the outpatient department of our hospital from February 1, 2014 to January 1, 2015 were selected in this study. 30 patients treated with small dose of azithromycin were set as control group, and 30 patients treated with singulair combined with small dose of azithromycin were set as experimental group. The clinical effects of the two groups were observed and compared. Results After therapy, the cough rating score of the experimental group was (0.81 ± 0.33) points, significantly better than (1.56 ± 0.72) points of the control group (P<0.05). The total effective rate of the experimental group was 93.33%, significantly higher than 73.33%of the control group (P<0.05). Conclusions Singulair combined with small dose of azithromycin has significant efficacy in the treatment of upper airway cough syndrome, which can effectively improve the symptoms of cough and deserve clinical application.
